Chlorhexidine Gel Versus Peri-Implant Inflammation- A Randomized Double Blind Placebo Control Study

Clinical Oral Implants Research - United Kingdom
doi 10.1111/clr.32_13356
Full Text
Abstract

Available in full text

Categories
Oral Surgery
Date
Authors
Publisher

Wiley

Related search

Peri-Implant Bone Resorption During Healing Abutment Placement: The Effect of a 0.20% Chlorhexidine Gel vs. Placebo—A Randomized Double Blind Controlled Human Study

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Chlorhexidine Alcohol Base Mouthrinse Versus Chlorhexidine Formaldehyde Base Mouthrinse Efficacy on Plaque Control: Double Blind, Randomized Clinical Trials

Medicina Oral, Patologia Oral y Cirugia Bucal
MedicineOtorhinolaryngologySurgeryDentistry
2013English

Chlorhexidine Gel Versus Internal Implant Bacterial Contamination: A Proof-Of-Concept Human Study

Clinical Oral Implants Research
Oral Surgery
2017English

Becaplermin Gel in the Treatment of Pressure Ulcers: A Phase II Randomized, Double-Blind, Placebo-Controlled Study

Wound Repair and Regeneration
DermatologySurgery
1999English

Minocycline Trial in Japanese Encephalitis: A Double Blind, Randomized Placebo Study

Pediatric Review: International Journal of Pediatric Research
2016English

Treatment of Peri-Implant Mucositis With Repeated Application of Chlorhexidine Chips or Gel During Supportive Therapy – A Randomized Clinical Trial

Dentistry Journal
Dentistry
2019English

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

PLoS ONE
Multidisciplinary
2013English

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

Placebo Effect of Medication Cost in Parkinson Disease: A Randomized Double-Blind Study

Neurology
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy